- 2018 American Transplant Congress - Kidney Registration Volume vs. Expectation: Impact of ESRD Burden and Outreach- United Network for Organ Sharing, Richmond, VA. Overall trends in waiting list registrations prior to KAS have predominately monotonically increased, albeit with varied rates of growth, since 2000. However, as a result…
- 2018 American Transplant Congress - Outcomes of C4d+ Immunostaining in Heart Transplantation: Is All Immunologic AMR Bad?- Cedars Sinai Medical Center, Los Angeles, CA. Purpose: Antibody-mediated rejection (AMR) remains a threat to patients (pts) following heart transplant (HTx). C4d immunostaining is one component involved in the diagnosis of AMR…
- 2018 American Transplant Congress - Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait TimesCytomegalovirus (CMV) infection is a major cause of morbidity and mortality in kidney transplant recipients.A pre-transplant allocation strategy by matching deceased kidney donors and recipients…
- 2018 American Transplant Congress - One-Pump versus Two-Pump Normothermic Ex Vivo Perfusion Machines in Discarded Human Livers- Transplant Surgery, Cleveland Clinic, Cleveland. Introduction:Physiologic flows and pressures need to be provided by the ex vivo liver perfusion device. We hypothesized that the 1-pump designed machines would provide the…
- 2018 American Transplant Congress - Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft FunctionPurpose: Delayed graft function (DGF) is associated with increased allogaft immunogenicity and decreased long-term survival. We hypothesized that high levels of donor urinary biomarkers for…
- 2018 American Transplant Congress - Are Donation after Cardiac Death (DCD) Kidneys Unsuitable for Pediatric Recipients?Introduction: Despite the fact that the number of pediatric patients listed for kidney transplantation far exceeds the supply of deceased donor kidneys, there is a…
- 2018 American Transplant Congress - Private Insurance is Associated with Reduce Access to HCV Therapy after Liver TransplantationEffective treatment for hepatitis C virus (HCV) infection has revolutionized post liver transplant (LTx) care. Administration of direct-acting antiviral agents (DAAs) after HCV+ LTx results…
- 2018 American Transplant Congress - Kidney Allograft Vascular Disease Post-Transplant (KTX): Risk Factors and Implications- 1Medicine, Mayo Clinic, Rochester, MN; 2Pathology, Mayo Clinic, Rochester, MN. Background: Over time grafts develop arteriosclerosis (ART)and arteriolar hyalinosis (AH). Previous studies associated AH with calcineurin inhibitors (CNI), diabetes (DM), kidney age and hypertension. Other…
- 2018 American Transplant Congress - Genomic Diversity of Epstein Barr Virus in Post-Transplant Lymphoproliferative DisorderPurpose: In transplant recipients, Epstein-Barr Virus (EBV) is associated with the development of B cell lymphomas in post-transplant lymphoproliferative disorder (PTLD). We utilized next-generation sequencing…
- 2018 American Transplant Congress - Identification of T Cells as Target of Intervention to Decrease Anti-LG3 Autoantibody Levels Prior to Transplantation- Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. Autoantibodies against perlecan/LG3 fragment (anti-LG3) have been associated with accelerated allograft rejection and long-term renal allograft dysfunction. Intriguingly, anti-LG3 are present prior to transplantation in…
- « Previous Page
- 1
- …
- 159
- 160
- 161
- 162
- 163
- …
- 211
- Next Page »
